C4 Therapeutics to Participate in Upcoming September Investor Conferences
C4 Therapeutics (Nasdaq: CCCC), a clinical-stage biopharmaceutical company focused on targeted protein degradation, has announced its participation in two upcoming investor conferences in September 2024. The company's management will engage in fireside chats at the following events:
- Wells Fargo Healthcare Conference in Boston, MA on September 5, 2024, at 8:45 AM ET
- 2024 Cantor Global Healthcare Conference in New York, NY on September 18, 2024, at 8:35 AM ET
Both events will feature live webcasts accessible through C4 Therapeutics' website, with archived replays available for approximately 30 days after the live events.
C4 Therapeutics (Nasdaq: CCCC), un'azienda biofarmaceutica in fase clinica focalizzata sulla degradazione mirata delle proteine, ha annunciato la sua partecipazione a due prossime conferenze per investitori nel settembre 2024. La direzione dell'azienda parteciperà a discussioni informali nei seguenti eventi:
- Wells Fargo Healthcare Conference a Boston, MA, il 5 settembre 2024, alle 8:45 AM ET
- 2024 Cantor Global Healthcare Conference a New York, NY, il 18 settembre 2024, alle 8:35 AM ET
Entrambi gli eventi presenteranno webcast dal vivo accessibili attraverso il sito web di C4 Therapeutics, con le registrazioni disponibili per circa 30 giorni dopo gli eventi dal vivo.
C4 Therapeutics (Nasdaq: CCCC), una empresa biofarmacéutica en etapa clínica enfocada en la degradación dirigida de proteínas, ha anunciado su participación en dos próximas conferencias para inversionistas en septiembre de 2024. La dirección de la empresa participará en charlas informales en los siguientes eventos:
- Wells Fargo Healthcare Conference en Boston, MA, el 5 de septiembre de 2024, a las 8:45 AM ET
- 2024 Cantor Global Healthcare Conference en Nueva York, NY, el 18 de septiembre de 2024, a las 8:35 AM ET
Ambos eventos contarán con transmisiones en vivo accesibles a través del sitio web de C4 Therapeutics, y se dispondrán repeticiones archivadas durante aproximadamente 30 días después de los eventos en vivo.
C4 Therapeutics(Nasdaq: CCCC)는 대상 단백질 분해에 초점을 맞춘 임상 단계의 생명공학 회사로 2024년 9월에 있을 두 개의 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사의 관리진은 다음 이벤트에서 비공식 대화에 참여할 예정입니다:
- 웰스파고 헬스케어 컨퍼런스가 2024년 9월 5일 오전 8:45(ET) 보스턴, MA에서 개최됩니다.
- 2024 칸토 글로벌 헬스케어 컨퍼런스는 2024년 9월 18일 오전 8:35(ET) 뉴욕, NY에서 개최됩니다.
두 행사 모두 C4 Therapeutics 웹사이트를 통해 접근 가능한 실시간 웹캐스트가 진행되며, 생중계 후 약 30일 동안 아카이브 재생이 제공됩니다.
C4 Therapeutics (Nasdaq: CCCC), une entreprise bio-pharmaceutique en phase clinique axée sur la dégradation ciblée des protéines, a annoncé sa participation à deux prochaines conférences pour investisseurs en septembre 2024. La direction de l'entreprise participera à des discussions informelles lors des événements suivants :
- Wells Fargo Healthcare Conference à Boston, MA, le 5 septembre 2024 à 8h45 ET
- 2024 Cantor Global Healthcare Conference à New York, NY, le 18 septembre 2024 à 8h35 ET
Les deux événements proposeront des webcasts en direct accessibles via le site Web de C4 Therapeutics, avec des rediffusions archivées disponibles pendant environ 30 jours après les événements en direct.
C4 Therapeutics (Nasdaq: CCCC), ein biopharmazeutisches Unternehmen in klinischer Phase, das sich auf gezielte Proteinabbau konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 angekündigt. Das Management des Unternehmens wird in den folgenden Veranstaltungen an informellen Gesprächen teilnehmen:
- Wells Fargo Healthcare Conference in Boston, MA am 5. September 2024 um 8:45 Uhr ET
- 2024 Cantor Global Healthcare Conference in New York, NY am 18. September 2024 um 8:35 Uhr ET
Beide Veranstaltungen bieten Live-Webcasts, die über die Website von C4 Therapeutics zugänglich sind, mit archivierten Wiederholungen, die etwa 30 Tage nach den Live-Events verfügbar sind.
- None.
- None.
WATERTOWN, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in fireside chats at two September investor conferences.
Fireside Chat Details:
Event: Wells Fargo Healthcare Conference taking place in Boston, MA
Date/Time: September 5, 2024 at 8:45 AM ET
Event: 2024 Cantor Global Healthcare Conference taking place in New York, New York
Date/Time: September 18, 2024 at 8:35 AM ET
Live webcasts will be available on the Investors section of the company’s website at www.c4therapeutics.com. Archived replays of the webcasts will be available for approximately 30 days following the live events.
About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.
Contacts:
Investors:
Courtney Solberg
Senior Manager, Investor Relations
CSolberg@c4therapeutics.com
Media:
Loraine Spreen
Senior Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com
FAQ
What investor conferences will C4 Therapeutics (CCCC) participate in during September 2024?
When and where is the Wells Fargo Healthcare Conference that C4 Therapeutics (CCCC) will attend?
What is the date and location of the 2024 Cantor Global Healthcare Conference where C4 Therapeutics (CCCC) will present?
How can investors access the webcasts of C4 Therapeutics (CCCC) presentations at the September 2024 conferences?
